Proceedings of the ATS workshop on refractory asthma: Current understanding, recommendations, and unanswered questions

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 6, 2000, Pages 2341-2351

  Wenzel, Sally E ^a,b   Fahy, John V ^b   Irvin, Charles ^b   Peters, Stephen P ^b   Spector, Sheldon ^b   Szefler, Stanley J ^b   Casale, Thomas B ^c   Cloutier, Michelle M ^d   Elias, Jack A ^e   Liu, Mark C ^f   Taggert, Virginia ^g  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b Creighton University ^*

^c CREIGHTON UNIVERSITY   (United States)

^d Farmington   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; FLUNISOLIDE; FLUTICASONE PROPIONATE; TRIAMCINOLONE ACETONIDE;

ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL FEATURE; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FORCED EXPIRATORY VOLUME; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0034526865     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.6.ats9-00     Document Type: Conference Paper

References (119)

1. Breathing better or wheezing worse? The changing epidemiology of asthma morbidity and mortality
2. Epidemiology of asthma
3. Total population survey of the frequency and severity of asthma in 17 year old boys in an urban area in Israel
4. Worldwide differences in asthma prevalence and mortality
5. An economic evaluation of asthma in the United States
6. A national estimate of the economic costs of asthma
7. Costs of asthma according to the degree of severity
8. Brittle asthma
9. Difficult-to-control asthma: Clinical characteristics of steroid-insensitive asthma
10. Asthma control versus asthma severity
11. Airway wall remodeling in asthma
12. A 15-year followup study of ventilatory function in adults with asthma
13. Adult patients may outgrow their asthma. A 25-year followup study
14. Followup of asthma from childhood to adulthood: Influence of potential childhood risk factors on the outcome of pulmonary function and bronchial responsiveness in adulthood
15. Natural history of childhood asthma
16. Mortality and decline in lung function in 213 adults with bronchial asthma: A ten-year followup
17. Decline of lung function in adults with bronchial asthma
18. Clinical diagnosis in adults
19. Difficult-to-control asthma: Contributing factors and outcome of a systematic management protocol
20. Pulmonary physiology of severe asthma in children and adults
21. Sudden asphyxic asthma: A distinct entity?
22. Pathological changes according to the severity of asthma
23. Airway remodeling is a distinctive feature of asthma and is related to severity of asthma
24. Collagen deposition in large airways does not appear to differentiate severe asthma from milder forms of the disease
25. Airway remodeling and persistent airway obstruction is asthma
26. Rate of decline of lung function in subjects with asthma
27. Asthma and irreversible airflow limitation
28. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children
29. Genetic susceptibility to asthma - Bronchial hyperresponsiveness coinherited with a major gene for atopy
30. Airways responsiveness in childhood as a predictor of the outcome of asthma in adulthood
31. The state of childhood asthma in young adulthood
32. Lung function in young adults who had asthma in childhood
33. Airway mechanics in asthma
34. Airways responsiveness standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults
35. The origin of airways hyperresponsiveness
36. 20 determination in a random selection of young college students
37. Bronchial reactivity to inhaled histamines: A method of clinical survey
38. Effect of lung volume on maximal methacholine involved bronchoconstriction in normal humans
39. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma
40. Relationship and airway hyperresponsiveness to respiratory symptoms and diurnal peak flow variation in patients with obstructive lung disease
41. Effect of early versus late intervention with inhaled corticosteroids in asthma
42. Asthma: Analysis of sudden deaths and ventilatory arrest in hospital
43. Perception of asthma
44. Throwing the baby out with the bath water
45. Peripheral lung resistance in normal and asthmatic subjects
46. Hyperpnea-induced changes in parenchymal lung mechanics in normal subjects and in asthmatics
47. Nocturnal asthma: Role of snoring and obstructive sleep apnea
48. Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma
49. Impaired perception of dyspnea in patients with severe asthma: Relation to sputum eosinophils
50. The effect of maternal smoking during pregnancy on early infant lung function
51. Asthma and wheezing in the first six years of life
52. Persistent wheeze: Its relation to respiratory illness, cigarette smoking, and level of pulmonary function in a population sample of children
53. Increased incidence of asthma in children of smoking mothers
54. Prospective study of risk factors for early and persistent wheezing in childhood
55. Asthma: Early predisposing factors
56. Maternal smoking during pregnancy and lower respiratory tract illness in early life
57. Effects of passive smoking on respiratory illness from birth to age eighteen months, in Shanghai, People's Republic of China
58. Prevalence of asthma and atopy in two areas of West and East Germany
59. Relationship between airway responsiveness and serum IgE in children with asthma and apparently normal children
60. Characteristics of asthma among elderly adults in a sample of the general population
61. Linkage analysis of IL-4 and other chromosome 5q31.1 markers and total serum IgE concentrations
62. Evidence for a locus regulating total serum IgE levels mapping to chromosome 5
63. Alternaria as a major allergen for asthma in children raised in a desert environment
64. Sensitization to dust mites as a dominant risk factor for asthma among adolescents living in central Virginia: Multiple regression analysis of a population-based study
65. Sensitization to cat allergen is associated with asthma in older men and predicts new-onset airway hyperresponsiveness: The normative aging study
66. Importance of genetic factors in adolescent asthma: A population-based twin study
67. Genetic and environmental risk factors for asthma: A cotwin-control study
68. 1 in asthma
69. Is sensitization to Alternaria alternata a risk factor for severe asthma? A population-based study
70. Effect of environmental molds on risk of death from asthma during the pollen season
71. The role of cockroach allergy and exposure to cockroach allergey in causing morbidity among inner-city children with asthma
72. Reduction of bronchial hyperreactivity during prolonged allergen avoidance
73. Respiratory viruses and exacerbations of asthma in adults
74. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children
75. Respiratory infections: Their role in airway responsiveness and the pathogenesis of asthma
76. Virus-induced airway hyperresponsiveness and asthma
77. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects
78. Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen
79. Respiratory syncytial virus infection prolongs methacholine-induced airway hyperresponsiveness in ovalbumin-sensitized mice
80. Occupational asthma
81. The effects of suggestion and emotional arousal on pulmonary function in asthma: A review and a hypothesis regarding vagal mediation
82. NHLBI workshop summary: Stress and asthma
83. Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy
84. Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma
85. Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma
86. Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma
87. In vivo resistance of glucocorticoids in bronchial asthma is associated with enhanced phosphrylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-terminal kinase phosphorylation
88. Reduced glucocorticoid binding affinity in asthma is related to ongoing allergic inflammation
89. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics
90. Bronchoscopic evaluation of severe asthma: Persistent inflammation associated with high dose glucocorticoids
91. Neutrophilic inflammation in severe persistent asthma
92. Sudden-onset fatal asthma - A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa?
93. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation
94. Bronchial neutrophilia in patients with noninfectious status asthmaticus
95. Pattern of airway inflammation and its determinants in children with acute severe asthma
96. Glucocorticoid treatment inhibits apoptosis in human neutrophils: Separation of survival and activation outcomes
97. Airway remodeling and repair
98. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma
99. Eosinophil-associated TGF-β1 mRNA expression and airway fibrosis in bronchial asthma
100. Interleukin-11 expression is increased in severe asthma: Association with epithelial cells and eosinophils
101. The structure of large and small airways in nonfatal and fatal asthma
102. Increased vascularity of the bronchial mucosa in mild asthma
103. Bronchial elastic fibers in normal subjects and asthmatic patients
104. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid
105. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma
106. Inflammatory cell distribution within and along asthmatic airways
107. Alveolar tissue inflammation in asthma
108. Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life
109. Improvement in health care utilization and pulmonary function in very severe asthmatics one year following initiation of fluticasone propionate (FP) therapy concurrent with evaluation at a national asthma referral center
110. Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: A double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma
111. Randomized, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients
112. Specific immunotherapy in asthma
113. Difficult to control asthma: New insights and implications for management
114. Monitoring glucocorticoid therapy: A pharmacokinetic approacb
115. Corticosteroid action resistance in asthma
116. Glucocorticoid insensitive asthma: Lessons for future asthma management
117. Alternative anti-inflammatory and immunomodulatory therapy
118. Treatment of the unusually difficult asthmatic patient